Last Posted: Oct 11, 2019
- New Precision Medicine Treatment Could Benefit Many Men with Treatment-Resistant Metastatic Prostate Cancer
by Andrea K. Miyahira, Prostate Cancer Foundation, October 1, 2019 - Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine-Learning Techniques.
Montoya Perez Ileana et al. Journal of magnetic resonance imaging : JMRI 2019 Oct - Clinical utility of emerging biomarkers in prostate cancer liquid biopsies.
Boerrigter Emmy et al. Expert review of molecular diagnostics 2019 Oct - Tissue-based genomics: which test and when.
Vince Randy A et al. Current opinion in urology 2019 Nov 29(6) 598-604 - Genome-wide germline correlates of the epigenetic landscape of prostate cancer
KE Houlahan et al, Nature Medicine, October 7, 2019 - Consensus Statement on Circulating Biomarkers for Advanced Prostate Cancer.
Sumanasuriya Semini et al. European urology oncology 2018 1(2) 151-159 - New name for breast-cancer syndrome could help to save lives.
Pritchard Colin C et al. Nature 2019 571(7763) 27-29 - Psychosocial impact of undergoing prostate cancer screening for men with BRCA1 or BRCA2 mutations.
Bancroft Elizabeth K et al. BJU international 2019 123(2) 284-292 - Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
Barcel? Maria et al. Scientific reports 2019 Sep 9(1) 13772 - [Genetic profiling in the diagnosis of hereditary prostate cancer: Where do we stand?]
Boehm Katharina et al. Aktuelle Urologie 2018 Dec 49(6) 525-529
.png)
No hay comentarios:
Publicar un comentario